CA Stock MarketDetailed Quotes

ME Therapeutics Holding Inc (METX)

Watchlist
  • 2.950
  • 0.0000.00%
15min DelayMarket Closed May 6 14:09 ET
88.65MMarket Cap-73.75P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ME Therapeutics Holding Inc (METX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Feb 28, 2026
(Q1)Nov 30, 2025
(FY)Aug 31, 2025
(Q4)Aug 31, 2025
(Q3)May 31, 2025
(Q2)Feb 28, 2025
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-65.44%-342.9K
-122.09%-322.79K
-31.07%-862.35K
-63.22%-245.25K
-84.98%-264.49K
-108.83%-207.27K
45.24%-145.34K
-117.00%-657.92K
-48.92%-150.26K
2.58%-142.98K
Net income from continuing operations
-44.63%-289.23K
-17.61%-354.43K
7.84%-1.19M
-8.45%-338.41K
28.74%-353.45K
-39.37%-199.98K
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
Depreciation and amortization
38.11%28.28K
151.98%26.52K
213,538.46%83.32K
295,022.22%26.56K
257,470.00%25.76K
186,063.64%20.48K
116,822.22%10.52K
-20.41%39
-25.00%9
-16.67%10
Remuneration paid in stock
--0
--0
-75.31%170.57K
--0
--0
159.73%17.97K
-26.49%152.6K
17.45%690.89K
-31.20%170.87K
-10.11%305.5K
Other non cashItems
-53.52%1.76K
-17.13%2.31K
48.16%12.72K
--2.82K
165.36%3.32K
29.32%3.79K
-36.70%2.79K
-99.85%8.58K
--0
-99.96%1.25K
Change In working capital
-69.04%-83.72K
128.45%2.82K
202.30%64.24K
801.12%63.78K
29.48%59.88K
-244.06%-49.53K
92.63%-9.89K
-247.48%-62.8K
-165.85%-9.1K
129.20%46.25K
-Change in receivables
618.01%16.23K
253.08%15.46K
-450.82%-51.61K
-878.71%-34.48K
-84.04%-9.3K
-90.17%2.26K
57.54%-10.1K
-160.76%-9.37K
-239.08%-3.52K
-228.20%-5.05K
-Change in prepaid assets
-323.05%-52.3K
114.69%8.7K
25.89%-5.84K
102.51%546
545.54%29.39K
-53.06%23.45K
-45.72%-59.21K
47.87%-7.87K
-41.89%-21.74K
-81.57%4.55K
-Change in payables and accrued expense
36.66%-47.65K
-135.92%-21.34K
367.13%121.69K
504.34%97.72K
-14.88%39.8K
-95.13%-75.23K
184.98%59.41K
-207.80%-45.56K
-46.42%16.17K
1,665.61%46.75K
Cash from discontinued investing activities
Operating cash flow
-65.44%-342.9K
-122.09%-322.79K
-31.07%-862.35K
-63.22%-245.25K
-84.98%-264.49K
-108.83%-207.27K
45.24%-145.34K
-117.00%-657.92K
-48.92%-150.26K
2.58%-142.98K
Investing cash flow
Cash flow from continuing investing activities
80.80%-29.58K
91.62%-1.65K
-284.54K
-44.58K
-66.2K
-154.04K
-19.73K
0
0
0
Net PPE purchase and sale
80.80%-29.58K
81.29%-1.65K
---216.15K
---44.58K
---8.7K
---154.04K
---8.83K
--0
--0
--0
Net business purchase and sale
----
----
----
----
----
----
----
--0
--0
----
Net investment purchase and sale
----
----
---57.5K
--0
----
----
----
--0
--0
----
Net other investing changes
----
----
---10.89K
--0
--0
--0
---10.89K
----
----
----
Cash from discontinued investing activities
Investing cash flow
80.80%-29.58K
91.62%-1.65K
---284.54K
---44.58K
---66.2K
---154.04K
---19.73K
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-101.62%-16.7K
3,174.24%167.42K
-33.96%995.54K
-117.83%-16.34K
-103.63%-16.34K
1.03M
-5.45K
1,204.91%1.51M
-106.49%-7.5K
450K
Net issuance payments of debt
-2.20%-16.7K
-204.39%-16.58K
-36.14%-54.46K
---16.34K
---16.34K
---16.34K
---5.45K
---40K
--0
--0
Net common stock issuance
----
----
--0
----
----
----
----
1,246.03%1.56M
--0
----
Proceeds from stock option exercised by employees
--0
--184K
14,100.00%1.05M
--0
--0
--1.05M
--0
---7.5K
---7.5K
--0
Net other financing activities
----
----
----
----
----
----
----
----
----
--450K
Cash from discontinued financing activities
Financing cash flow
-101.62%-16.7K
3,174.24%167.42K
-33.96%995.54K
-117.83%-16.34K
-103.63%-16.34K
--1.03M
---5.45K
1,204.91%1.51M
-106.49%-7.5K
--450K
Net cash flow
Beginning cash position
-10.39%1.19M
-10.11%1.35M
131.28%1.5M
-0.18%1.65M
48.32%2M
247.43%1.33M
131.28%1.5M
736.35%647.15K
161.57%1.65M
6,066.33%1.35M
Current changes in cash
-157.88%-389.18K
7.91%-157.02K
-117.81%-151.35K
-94.07%-306.17K
-213.03%-347.02K
-30.38%672.35K
35.76%-170.52K
49.11%849.58K
-1,178.77%-157.76K
-49.72%307.02K
End cash Position
-60.01%799.17K
-10.39%1.19M
-10.11%1.35M
-10.11%1.35M
-0.18%1.65M
48.32%2M
247.43%1.33M
131.28%1.5M
131.28%1.5M
161.57%1.65M
Free cash from
-3.09%-372.49K
-110.44%-324.45K
-63.93%-1.08M
-92.88%-289.83K
-91.06%-273.18K
-264.04%-361.31K
41.91%-154.18K
-117.00%-657.92K
-48.92%-150.26K
2.58%-142.98K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Feb 28, 2026(Q1)Nov 30, 2025(FY)Aug 31, 2025(Q4)Aug 31, 2025(Q3)May 31, 2025(Q2)Feb 28, 2025(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -65.44%-342.9K-122.09%-322.79K-31.07%-862.35K-63.22%-245.25K-84.98%-264.49K-108.83%-207.27K45.24%-145.34K-117.00%-657.92K-48.92%-150.26K2.58%-142.98K
Net income from continuing operations -44.63%-289.23K-17.61%-354.43K7.84%-1.19M-8.45%-338.41K28.74%-353.45K-39.37%-199.98K12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K
Depreciation and amortization 38.11%28.28K151.98%26.52K213,538.46%83.32K295,022.22%26.56K257,470.00%25.76K186,063.64%20.48K116,822.22%10.52K-20.41%39-25.00%9-16.67%10
Remuneration paid in stock --0--0-75.31%170.57K--0--0159.73%17.97K-26.49%152.6K17.45%690.89K-31.20%170.87K-10.11%305.5K
Other non cashItems -53.52%1.76K-17.13%2.31K48.16%12.72K--2.82K165.36%3.32K29.32%3.79K-36.70%2.79K-99.85%8.58K--0-99.96%1.25K
Change In working capital -69.04%-83.72K128.45%2.82K202.30%64.24K801.12%63.78K29.48%59.88K-244.06%-49.53K92.63%-9.89K-247.48%-62.8K-165.85%-9.1K129.20%46.25K
-Change in receivables 618.01%16.23K253.08%15.46K-450.82%-51.61K-878.71%-34.48K-84.04%-9.3K-90.17%2.26K57.54%-10.1K-160.76%-9.37K-239.08%-3.52K-228.20%-5.05K
-Change in prepaid assets -323.05%-52.3K114.69%8.7K25.89%-5.84K102.51%546545.54%29.39K-53.06%23.45K-45.72%-59.21K47.87%-7.87K-41.89%-21.74K-81.57%4.55K
-Change in payables and accrued expense 36.66%-47.65K-135.92%-21.34K367.13%121.69K504.34%97.72K-14.88%39.8K-95.13%-75.23K184.98%59.41K-207.80%-45.56K-46.42%16.17K1,665.61%46.75K
Cash from discontinued investing activities
Operating cash flow -65.44%-342.9K-122.09%-322.79K-31.07%-862.35K-63.22%-245.25K-84.98%-264.49K-108.83%-207.27K45.24%-145.34K-117.00%-657.92K-48.92%-150.26K2.58%-142.98K
Investing cash flow
Cash flow from continuing investing activities 80.80%-29.58K91.62%-1.65K-284.54K-44.58K-66.2K-154.04K-19.73K000
Net PPE purchase and sale 80.80%-29.58K81.29%-1.65K---216.15K---44.58K---8.7K---154.04K---8.83K--0--0--0
Net business purchase and sale ------------------------------0--0----
Net investment purchase and sale -----------57.5K--0--------------0--0----
Net other investing changes -----------10.89K--0--0--0---10.89K------------
Cash from discontinued investing activities
Investing cash flow 80.80%-29.58K91.62%-1.65K---284.54K---44.58K---66.2K---154.04K---19.73K--0--0--0
Financing cash flow
Cash flow from continuing financing activities -101.62%-16.7K3,174.24%167.42K-33.96%995.54K-117.83%-16.34K-103.63%-16.34K1.03M-5.45K1,204.91%1.51M-106.49%-7.5K450K
Net issuance payments of debt -2.20%-16.7K-204.39%-16.58K-36.14%-54.46K---16.34K---16.34K---16.34K---5.45K---40K--0--0
Net common stock issuance ----------0----------------1,246.03%1.56M--0----
Proceeds from stock option exercised by employees --0--184K14,100.00%1.05M--0--0--1.05M--0---7.5K---7.5K--0
Net other financing activities --------------------------------------450K
Cash from discontinued financing activities
Financing cash flow -101.62%-16.7K3,174.24%167.42K-33.96%995.54K-117.83%-16.34K-103.63%-16.34K--1.03M---5.45K1,204.91%1.51M-106.49%-7.5K--450K
Net cash flow
Beginning cash position -10.39%1.19M-10.11%1.35M131.28%1.5M-0.18%1.65M48.32%2M247.43%1.33M131.28%1.5M736.35%647.15K161.57%1.65M6,066.33%1.35M
Current changes in cash -157.88%-389.18K7.91%-157.02K-117.81%-151.35K-94.07%-306.17K-213.03%-347.02K-30.38%672.35K35.76%-170.52K49.11%849.58K-1,178.77%-157.76K-49.72%307.02K
End cash Position -60.01%799.17K-10.39%1.19M-10.11%1.35M-10.11%1.35M-0.18%1.65M48.32%2M247.43%1.33M131.28%1.5M131.28%1.5M161.57%1.65M
Free cash from -3.09%-372.49K-110.44%-324.45K-63.93%-1.08M-92.88%-289.83K-91.06%-273.18K-264.04%-361.31K41.91%-154.18K-117.00%-657.92K-48.92%-150.26K2.58%-142.98K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 -0.13%
Sample Name
Sample Code
 -1.05%
4
SHANGHAI PECHEM
00338
-1.56%
5
SINOPEC CORP
00386
-2.39%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.26%
Sample Name
Sample Code
 +31.66%
Sample Name
Sample Code
 +26.25%
4
Digital China Group
000034
+15.29%
5
Loongson Technology Corporation
688047
+12.74%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -